supported by the National Key Research and Development Program of China(2021YFE0206600);the Sichuan Province Science and Technology Support Program(2021YF-SY0008 and 2020YJ023,China);the Translational Medicine Fund of West China Hospital(CGZH19002,China);the 1.3.5 Project for Disciplines of excellence,West China Hospital,Sichuan University(ZYGD18020/ZYJC18006,China).
The extraordinary advantages associated with mRNA vaccines,including their high efficiency,relatively low severity of side effects,and ease of manufacture,have enabled them to be a promising immunotherapy approach aga...
financially supported by National Natural Science Foundation of China (Nos. 82072059 and 82172090);CAMS Initiative for Innovative Medicine (No. 2021-I2M-1-058);the Fundamental Research Funds for the Central Universities (Nos. 2019PT320028 and 2019-0831-03);Tianjin Municipal Natural Science Foundation (No. 20JCYBJC00030)
Since antigen and adjuvant are rapid clearance in vivo,insufficient delivery to induce dendritic cells(DCs)maturation and cross-presentation,as well as limited migration efficiency of DCs to secondary lymph organs,gre...
National Natural Science Foundation of China (Grant No.30701056);Foundation of MOST(973 Program,Grant No.2007CB935801);Beijing Natural Science Foundation of China (Grant No.7083112);Doctoral Fund of Ministry of Education of China(Grant No.20070001813).
This study aimed to investigate the effects of cationic liposomes containing different cationic lipids (DC-Chol and DOTAP) and different pegylation ratios on siRNA transfection in human U251 glioma cells. The data s...